BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pfizer Inc. (PFE) Anti-Smoking Drug Tied to Blackouts


9/1/2011 8:01:27 AM

A U.S.-made drug to help smokers quit has been tied to several cases of impaired awareness, causing at least one car crash, the Ministry of Health, Labor and Welfare announced on Aug. 30. The ministry stated that it had received six reports of impaired awareness stemming from U.S. pharmaceutical giant Pfizer Inc.'s Varenicline -- sold under the trade name Champix -- between its May 2008 Japanese release and April this year. According to the health ministry, the six cases of impaired awareness occurred among both male and female patients between the ages of 40 and 79. One patient in his 60s was behind the wheel of his car when he began shivering, blacked out and drove the vehicle into a ditch about 20 minutes after taking the drug.


   
Addiction

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES